Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 14 | 2026 | 241 | 4.620 |
Why?
|
| Chromatography, Liquid | 9 | 2026 | 182 | 1.480 |
Why?
|
| Rats | 20 | 2026 | 3735 | 1.330 |
Why?
|
| Reproducibility of Results | 12 | 2026 | 1081 | 1.150 |
Why?
|
| Nanoparticles | 3 | 2022 | 460 | 1.040 |
Why?
|
| Chromatography, High Pressure Liquid | 8 | 2025 | 465 | 0.950 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2026 | 1766 | 0.950 |
Why?
|
| Nanomedicine | 3 | 2021 | 52 | 0.860 |
Why?
|
| Griseofulvin | 1 | 2024 | 4 | 0.860 |
Why?
|
| Mycophenolic Acid | 2 | 2025 | 16 | 0.840 |
Why?
|
| Indoles | 1 | 2025 | 187 | 0.840 |
Why?
|
| Tissue Distribution | 7 | 2025 | 240 | 0.830 |
Why?
|
| Animals | 30 | 2026 | 16992 | 0.830 |
Why?
|
| Copper Radioisotopes | 3 | 2012 | 9 | 0.780 |
Why?
|
| Gold | 6 | 2012 | 156 | 0.760 |
Why?
|
| Plasma | 1 | 2022 | 38 | 0.710 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 1019 | 0.710 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2012 | 186 | 0.670 |
Why?
|
| Aminopyridines | 1 | 2020 | 26 | 0.650 |
Why?
|
| Oxyquinoline | 1 | 2020 | 6 | 0.650 |
Why?
|
| Linear Models | 5 | 2026 | 317 | 0.640 |
Why?
|
| Microsomes, Liver | 3 | 2025 | 75 | 0.630 |
Why?
|
| Tongue | 1 | 2019 | 16 | 0.620 |
Why?
|
| Communicable Diseases | 1 | 2020 | 47 | 0.610 |
Why?
|
| Chloroquinolinols | 1 | 2018 | 4 | 0.580 |
Why?
|
| Glucuronides | 4 | 2025 | 25 | 0.550 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 458 | 0.540 |
Why?
|
| Anilides | 2 | 2017 | 28 | 0.480 |
Why?
|
| Cyclohexanes | 2 | 2017 | 30 | 0.470 |
Why?
|
| Nanoshells | 2 | 2012 | 2 | 0.460 |
Why?
|
| Drug Stability | 3 | 2026 | 129 | 0.460 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2014 | 97 | 0.450 |
Why?
|
| Solubility | 3 | 2025 | 139 | 0.420 |
Why?
|
| Male | 15 | 2026 | 23409 | 0.420 |
Why?
|
| Itraconazole | 1 | 2013 | 13 | 0.420 |
Why?
|
| Nanospheres | 1 | 2013 | 7 | 0.420 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 48 | 0.410 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 93 | 0.400 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 81 | 0.390 |
Why?
|
| Lactic Acid | 1 | 2013 | 112 | 0.390 |
Why?
|
| Chromans | 1 | 2012 | 16 | 0.370 |
Why?
|
| Drug Carriers | 1 | 2013 | 174 | 0.370 |
Why?
|
| Antifungal Agents | 1 | 2013 | 169 | 0.360 |
Why?
|
| Vitamin E | 1 | 2012 | 62 | 0.360 |
Why?
|
| Limit of Detection | 3 | 2026 | 94 | 0.350 |
Why?
|
| Neoplasms | 1 | 2022 | 1377 | 0.340 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2011 | 18 | 0.340 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 29 | 0.330 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 62 | 0.320 |
Why?
|
| Sensitivity and Specificity | 4 | 2026 | 611 | 0.320 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 277 | 0.300 |
Why?
|
| Protein Binding | 4 | 2024 | 1082 | 0.290 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1596 | 0.290 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2024 | 140 | 0.290 |
Why?
|
| Nanotechnology | 4 | 2005 | 176 | 0.290 |
Why?
|
| Gold Colloid | 3 | 2005 | 5 | 0.280 |
Why?
|
| Mice | 8 | 2026 | 6644 | 0.270 |
Why?
|
| Rats, Nude | 3 | 2012 | 6 | 0.260 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 43 | 0.260 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 230 | 0.250 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2676 | 0.250 |
Why?
|
| Peptides | 3 | 2005 | 372 | 0.250 |
Why?
|
| Light | 1 | 2007 | 185 | 0.240 |
Why?
|
| Cytidine | 1 | 2026 | 5 | 0.240 |
Why?
|
| Caco-2 Cells | 1 | 2025 | 64 | 0.240 |
Why?
|
| Humans | 16 | 2025 | 43102 | 0.240 |
Why?
|
| Deoxycytidine | 1 | 2026 | 38 | 0.230 |
Why?
|
| Liver | 2 | 2026 | 511 | 0.230 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2025 | 127 | 0.230 |
Why?
|
| Piperidines | 1 | 2025 | 83 | 0.230 |
Why?
|
| Diclofenac | 1 | 2024 | 5 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 388 | 0.220 |
Why?
|
| Glycosides | 1 | 2024 | 23 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 94 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 347 | 0.210 |
Why?
|
| Species Specificity | 1 | 2024 | 286 | 0.210 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2003 | 5 | 0.210 |
Why?
|
| Injections, Intralesional | 2 | 2014 | 11 | 0.210 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 108 | 0.200 |
Why?
|
| Phenols | 1 | 2024 | 107 | 0.200 |
Why?
|
| Biological Availability | 2 | 2021 | 116 | 0.190 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 67 | 0.180 |
Why?
|
| Molecular Structure | 2 | 2024 | 570 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2022 | 97 | 0.180 |
Why?
|
| Kidney | 2 | 2024 | 372 | 0.180 |
Why?
|
| Liposomes | 1 | 2022 | 132 | 0.180 |
Why?
|
| Hydrazones | 1 | 2020 | 11 | 0.170 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 98 | 0.160 |
Why?
|
| Chemistry, Physical | 1 | 2020 | 50 | 0.160 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 65 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2012 | 259 | 0.160 |
Why?
|
| Neutron Activation Analysis | 2 | 2010 | 2 | 0.150 |
Why?
|
| Thermodynamics | 1 | 2020 | 229 | 0.150 |
Why?
|
| Heart | 1 | 2020 | 184 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2017 | 158 | 0.140 |
Why?
|
| Serum Albumin, Bovine | 4 | 2004 | 49 | 0.130 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2017 | 50 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 144 | 0.120 |
Why?
|
| Particle Size | 3 | 2007 | 272 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2017 | 383 | 0.120 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.110 |
Why?
|
| Proline | 1 | 2014 | 40 | 0.110 |
Why?
|
| Freeze Drying | 1 | 2013 | 29 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 11 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 74 | 0.100 |
Why?
|
| Solvents | 1 | 2013 | 113 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 140 | 0.100 |
Why?
|
| Kinetics | 2 | 2024 | 695 | 0.090 |
Why?
|
| Curcumin | 1 | 2013 | 118 | 0.090 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 13 | 0.090 |
Why?
|
| Laser Therapy | 1 | 2011 | 25 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 28 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 245 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 151 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 129 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2011 | 141 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1604 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2011 | 408 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 458 | 0.080 |
Why?
|
| Octoxynol | 1 | 2007 | 19 | 0.070 |
Why?
|
| Spectrophotometry | 2 | 2004 | 63 | 0.060 |
Why?
|
| Calibration | 1 | 2007 | 63 | 0.060 |
Why?
|
| Cattle | 2 | 2004 | 498 | 0.060 |
Why?
|
| Flavonoids | 1 | 2025 | 100 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2024 | 13 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 15 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 204 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2025 | 69 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1180 | 0.050 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2003 | 3 | 0.050 |
Why?
|
| Fluorescamine | 1 | 2003 | 3 | 0.050 |
Why?
|
| Flocculation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Ruthenium Compounds | 1 | 2003 | 2 | 0.050 |
Why?
|
| Succinimides | 1 | 2003 | 12 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 22 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 109 | 0.050 |
Why?
|
| Coordination Complexes | 1 | 2003 | 28 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 104 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 51 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 146 | 0.050 |
Why?
|
| Sulfites | 1 | 2023 | 13 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 184 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 171 | 0.050 |
Why?
|
| Nanostructures | 1 | 2005 | 161 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 109 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 388 | 0.050 |
Why?
|
| Microsomes | 1 | 2022 | 55 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2022 | 21 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2026 | 403 | 0.050 |
Why?
|
| Protein Transport | 2 | 2017 | 296 | 0.040 |
Why?
|
| Electron Transport | 1 | 2001 | 47 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 1869 | 0.040 |
Why?
|
| Female | 3 | 2026 | 24698 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 136 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 13 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 189 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 173 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 228 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 934 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 780 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 21 | 0.030 |
Why?
|
| Polysorbates | 1 | 2013 | 11 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 256 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 376 | 0.020 |
Why?
|
| Ethanol | 1 | 2013 | 224 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 968 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 449 | 0.020 |
Why?
|
| Polylysine | 1 | 2004 | 9 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 21 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 27 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2004 | 64 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2004 | 36 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 92 | 0.010 |
Why?
|
| Axons | 1 | 2004 | 117 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 311 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 114 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 423 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 313 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 508 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 2001 | 13 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 33 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 594 | 0.010 |
Why?
|
| Catalase | 1 | 2001 | 110 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1542 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1621 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 13872 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1263 | 0.010 |
Why?
|